Trial Profile
Effect of Olmesartan on Endothelial Dysfunction After Everolimus Eluting Stent Implantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Amlodipine; Everolimus
- Indications Coronary artery disease; Hypertension
- Focus Therapeutic Use
- 20 Apr 2012 New trial record